(Q46965074)

26 December 2017

title

New chelation therapies and emerging chelating drugs for the treatment of iron overload (English)

1 reference

26 December 2017

main subject

chelation therapy

0 references

author

George J Kontoghiorghes

series ordinal

1

object named as

George J Kontoghiorghes

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

26 December 2017

Expert Opinion on Emerging Drugs

published in

1 reference

26 December 2017

volume

11

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

1-5

1 reference

26 December 2017

Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

Ultrastructural pathology of the heart in patients with beta-thalassaemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

Iron-chelating therapy with the new oral agent ICL670 (Exjade).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

First human studies with a high-molecular-weight iron chelator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.1

21 January 2018

Identifiers

DOI

10.1517/14728214.11.1.1

1 reference

26 December 2017

1 reference

26 December 2017